In Brief: Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Perrigo: Has ceased production of its phenolphthalein-containing laxative, similar to Novartis' now reformulated Ex-Lax, but the private labeler says it intends to sell remaining shelf inventory rather than recall the product. Perrigo likely will reformulate its phenolphthalein-containing product with senna, as did Novartis. Leiner's private-label laxative containing senna is on shelves after shipping in November. The company voluntarily recalled its phenolphthalein-containing laxatives from store shelves in response to FDA's proposed ban of the ingredient due to possible carcinogenicity ("The Tan Sheet" Sept. 1, p. 1)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning